批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2020/04/23 |
SUPPL-61(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/04/21 |
SUPPL-62(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2019/10/22 |
SUPPL-60(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/03/27 |
SUPPL-59(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/02/23 |
SUPPL-58(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2017/02/23 |
SUPPL-57(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/10/27 |
SUPPL-55(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2016/10/06 |
SUPPL-56(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2015/07/23 |
SUPPL-49(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/12/19 |
SUPPL-48(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/09/30 |
SUPPL-44(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/08/11 |
SUPPL-52(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2010/12/01 |
SUPPL-45(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2010/05/27 |
SUPPL-43(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/05/27 |
SUPPL-39(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/01/27 |
SUPPL-37(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/08/31 |
SUPPL-36(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2008/08/14 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/07/06 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/11/29 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/08/25 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/02/23 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/02/16 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/02/16 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/09/13 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/03/29 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:OLANZAPINE 剂型/给药途径:INJECTABLE;INTRAMUSCULAR 规格:10MG/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021253 |
001 |
NDA |
ZYPREXA |
OLANZAPINE |
INJECTABLE;INTRAMUSCULAR |
10MG/VIAL |
Prescription |
Yes |
Yes |
AP |
2004/03/29
|
CHEPLAPHARM |
201588 |
001 |
ANDA |
OLANZAPINE |
OLANZAPINE |
INJECTABLE;INTRAMUSCULAR |
10MG/VIAL |
Prescription |
No |
No |
AP |
2011/10/24
|
SANDOZ INC |
201741 |
001 |
ANDA |
OLANZAPINE |
OLANZAPINE |
INJECTABLE;INTRAMUSCULAR |
10MG/VIAL |
Prescription |
No |
No |
AP |
2012/03/20
|
AM REGENT |
210968 |
001 |
ANDA |
OLANZAPINE |
OLANZAPINE |
INJECTABLE;INTRAMUSCULAR |
10MG/VIAL |
Prescription |
No |
No |
AP |
2020/10/22
|
EUGIA PHARMA |
217466 |
001 |
ANDA |
OLANZAPINE |
OLANZAPINE |
INJECTABLE;INTRAMUSCULAR |
10MG/VIAL |
Prescription |
No |
No |
AP |
2023/03/22
|
ASPIRO |